The Food and Drug Administration yesterday alerted pharmacy and nursing professionals to a voluntary recall of seven lots of an injectable drug used to treat certain serious bacterial infections, which may contain glass particulate matter. The Teva Pharmaceuticals Amikacin Sulfate Injection USP vials were distributed nationwide through wholesalers, retailers and pharmacies. Anyone with an existing inventory of the recalled lots should stop using and quarantine the product immediately, FDA said. Health care professionals and patients are encouraged to report adverse events or side effects related to the use of the product to the FDA's MedWatch program.

Headline
Pennsylvania has recorded its seventh measles-associated death this year as a statewide outbreak of the virus continues, according to an update Nov. 13 by the…
Headline
Erica Taylor, M.D., orthopedic surgeon and vice president of health equity at Duke Health, shares how the organization’s frontline liaison network is helping…
Headline
The Food and Drug Administration is seeking feedback on a discussion paper released Nov. 6 on the benefits and risks of robotic medical devices with autonomous…
Headline
The Wisconsin Department of Health Services reported Nov. 5 that an infant died of measles, marking the first measles-associated death in the state since 1990.…
Headline
The New York State Department of Health announced Nov. 2 that a child died of measles amid the state’s ongoing outbreak and is the first known measles…
Headline
There have been 1,398 confirmed cases of measles in Pennsylvania this year, according to data released Oct. 28 by the Pennsylvania Department of Health. Data…